News

Not sure about the Covid-19 vaccine jab? Experts discover a new alternative that may work better
To understand the mechanism of the nasal vaccines, the researchers first injected mice with a traditional mRNA COVID-19 shot, ...
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
Trump Administration Releases New COVID-19 Vaccine Plan: What to Know
In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well ...
FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
FDA will limit COVID-19 vaccine to those over 65 or at high risk
The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...
Onlymyhealth1h
New COVID-19 Vaccine Policy: Trump Administration Declares A Shift In Access For Healthy Americans
Under the new guidelines updated COVID-19 shots will continue be available for adults aged 65 and older as well as children ...
FDA announces change to future Covid-19 vaccine approvals that will limit fall boosters
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans. The agency is changing ...
FDA approves Novavax's COVID-19 vaccine with limitations
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
New COVID-19 vaccine requirements from FDA
Dr. Peter Chin Hong, a Bay Area infectious disease expert, discusses the stricter policy from the Food and Drug ...
Blavity on MSN15h
COVID-19 Vaccines Will Be Restricted From Healthy Adults And Kids Per Trump FDA’s Plan
The approval process for COVID-19 vaccines is going to look very different in the U.S. In a nutshell, Trump officials no ...
Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19
Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the Company has voluntarily withdrawn the pending Biologics License Application (BLA ...